Grain-Oriented Electrical Steel From China, Czech Republic, Germany, Japan, Korea, Poland, and Russia; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations, 59059-59060 [2013-23277]

Download as PDF Federal Register / Vol. 78, No. 186 / Wednesday, September 25, 2013 / Notices because of their education, training, or experience that enables them to give informed and objective advice regarding the interest they represent. They should demonstrate experience or knowledge of the area of their expertise and a commitment to collaborate in seeking solutions to resource management issues. The Board is structured to provide fair membership and balance, both geographic and interest specific, in terms of the functions to be performed and points of view to be represented. Members are selected with the objective of providing representative counsel and advice about public land and resource planning. No person is to be denied an opportunity to serve because of race, age, sex, religion, or national origin. The Obama Administration prohibits individuals who are currently federally registered lobbyists to serve on all FACA and non-FACA boards, committees or councils. Pursuant to Section 7 of the Wild Free-Roaming Horses and Burros Act, members of the Board cannot be employed by either Federal or state governments. Authority: 43 CFR 1784.4–1. Edwin L. Roberson, Assistant Director, Renewable Resources and Planning. [FR Doc. 2013–23340 Filed 9–24–13; 8:45 am] BILLING CODE 4310–84–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–505 and 731– TA–1231–1237 (Preliminary)] Grain-Oriented Electrical Steel From China, Czech Republic, Germany, Japan, Korea, Poland, and Russia; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations United States International Trade Commission. ACTION: Notice. AGENCY: The Commission hereby gives notice of the institution of investigations and commencement of preliminary phase antidumping and countervailing duty investigations Nos. 701–TA–505 and 731–TA–1231–1237 (Preliminary) under sections 703(a) and 733(a) of the Tariff Act of 1930 (19 U.S.C. 1671b(a) and 1673b(a)) (the Act) to determine whether there is a reasonable indication that an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:20 Sep 24, 2013 Jkt 229001 imports from China of grain-oriented electrical steel (‘‘GOES’’), provided for in subheadings 7225.11.00, 7226.11.10, and 7226.11.90 of the Harmonized Tariff Schedule of the United States, that are alleged to be subsidized by the Government of China and imports from China, Czech Republic, Germany, Japan, Korea, Poland, and Russia that are alleged to be sold in the United States at less than fair value. Unless the Department of Commerce extends the time for initiation pursuant to sections 702(c)(1)(B) or 732(c)(1)(B) of the Act (19 U.S.C. 1671a(c)(1)(B) or 1673a(c)(1)(B)), the Commission must reach a preliminary determination in antidumping and countervailing duty investigations in 45 days, or in this case by November 4, 2013. The Commission’s views are to be issued within five business days thereafter, or by November 12, 2013. For further information concerning the conduct of these investigations and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subparts A and B (19 CFR part 207). DATES: Effective September 18, 2013. FOR FURTHER INFORMATION CONTACT: Mary Messer (202–205–3193), Office of Investigations, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436. Hearingimpaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (http:// www.usitc.gov). The public record for these investigations may be viewed on the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. SUPPLEMENTARY INFORMATION: Background.—These investigations are being instituted in response to a petition filed on September 18, 2013, by AK Steel Corporation, West Chester, Ohio; Allegheny Ludlum, LLC, Pittsburgh, Pennsylvania; and the United Steelworkers, Pittsburgh, Pennsylvania. Participation in the investigations and public service list.—Persons (other than petitioners) wishing to participate in the investigations as parties must file an entry of appearance with the Secretary to the Commission, as provided in sections 201.11 and 207.10 of the Commission’s rules, not later than seven PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 59059 days after publication of this notice in the Federal Register. Industrial users and (if the merchandise under investigation is sold at the retail level) representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to these investigations upon the expiration of the period for filing entries of appearance. Limited disclosure of business proprietary information (BPI) under an administrative protective order (APO) and BPI service list.—Pursuant to section 207.7(a) of the Commission’s rules, the Secretary will make BPI gathered in these investigations available to authorized applicants representing interested parties (as defined in 19 U.S.C. 1677(9)) who are parties to the investigations under the APO issued in the investigations, provided that the application is made not later than seven days after the publication of this notice in the Federal Register. A separate service list will be maintained by the Secretary for those parties authorized to receive BPI under the APO. Conference.—The Commission’s Director of Investigations has scheduled a conference in connection with these investigations for 9:30 a.m. on October 9, 2013, at the U.S. International Trade Commission Building, 500 E Street SW., Washington, DC. Requests to appear at the conference should be filed with William.Bishop@usitc.gov and Sharon.Bellamy@usitc.gov (DO NOT FILE ON EDIS) on or before October 7, 2013. Parties in support of the imposition of countervailing and antidumping duties in these investigations and parties in opposition to the imposition of such duties will each be collectively allocated one hour within which to make an oral presentation at the conference. A nonparty who has testimony that may aid the Commission’s deliberations may request permission to present a short statement at the conference. Written submissions.—As provided in sections 201.8 and 207.15 of the Commission’s rules, any person may submit to the Commission on or before October 15, 2013, a written brief containing information and arguments pertinent to the subject matter of the investigations. Parties may file written testimony in connection with their presentation at the conference no later than three days before the conference. If briefs or written testimony contain BPI, they must conform with the E:\FR\FM\25SEN1.SGM 25SEN1 59060 Federal Register / Vol. 78, No. 186 / Wednesday, September 25, 2013 / Notices requirements of sections 201.6, 207.3, and 207.7 of the Commission’s rules. The Commission’s Handbook on EFiling, available on the Commission’s Web site at http://edis.usitc.gov, elaborates upon the Commission’s rules with respect to electronic filing. In accordance with sections 201.16(c) and 207.3 of the rules, each document filed by a party to the investigations must be served on all other parties to the investigations (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. Authority: These investigations are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.12 of the Commission’s rules. Issued: September 19, 2013. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2013–23277 Filed 9–24–13; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration mstockstill on DSK4VPTVN1PROD with NOTICES Gabriel Sanchez, M.D.; Decision and Order On August 14, 2012, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Gabriel Sanchez, M.D. (hereinafter, Registrant), of Delray Beach, Florida. The Show Cause Order proposed the revocation of Registrant’s DEA Certification of Registration AS9790420, and the denial of any pending applications for renewal or modification of the registration, on the ground that his ‘‘continued registration is inconsistent with the public interest.’’ GX 9, at 1 (citing 21 U.S.C. 824(a)(4) and 823(f)). The Show Cause Order alleged that in July of 2010, the Registrant issued prescriptions for oxycodone, a schedule II controlled substance, and carisoprodol, a schedule IV controlled substance under Florida law, to two undercover law enforcement officers (UCs). Id. The Show Cause Order alleged that these prescriptions ‘‘were not for a legitimate medical purpose in the usual course of professional practice because’’ the Registrant: (1) Did not ‘‘provide a legitimate diagnosis to warrant’’ the prescriptions; (2) ‘‘failed to conduct a sufficient physical exam to VerDate Mar<15>2010 17:20 Sep 24, 2013 Jkt 229001 determine a legitimate medical need’’ for the controlled substance prescriptions; (3) ‘‘prescribed controlled substances to the UCs despite evidence that they had illegally obtained, and were attempting to illegally obtain and abuse controlled substances’’; and (4) ‘‘prescribed oxycodone in large quantities to the UCs absent any reliable evidence’’ that they were opioid tolerant. Id. at 1–2. The Show Cause Order thus alleged that the oxycodone prescriptions issued by the Registrant ‘‘to the UCs were for other than a legitimate medical purpose in the usual course of professional practice in violation of Federal law.’’ Id. at 2 (citing 21 U.S.C. 829, 841(a) and 21 CFR 1306.04(a), 1301.71). Additionally, the Show Cause Order alleged that ‘‘[t]he prescriptions for oxycodone and carisoprodol that [the Registrant] issued to the UCs’’ violated Florida law because the prescriptions ‘‘were for other than a legitimate medical purpose in the usual course of professional practice.’’ Id. (citing Fla. Stat. Ann. § 456.072(1)(gg) and Fla. Admin. Code r. 64B8–9.013). The Show Cause Order also notified the Registrant of his right to either request a hearing on the allegations or to submit a written statement in lieu of a hearing, the procedures for electing either option, and the consequences of failing to do either. Id. On August 16, 2012, the Government accomplished service by personally serving the Registrant with the Order to Show Cause at the DEA Miami Field Division. GX 6. Registrant neither submitted a request for a hearing nor a written statement in lieu of a hearing. Req. for Final Agency Action, at 1. On May 20, 2012, the Government submitted a Request for Final Agency Action along with the investigative record it compiled. Having reviewed the record, I find that more than thirty days have now passed since the date of service of the Show Cause Order and neither Registrant, nor any one purporting to represent him, has filed a request for hearing or submitted a written statement in lieu of a hearing. Accordingly, I find that Registrant has waived his right to a hearing or to submit a written statement in lieu of a hearing and issue this Decision and Final Order based on relevant evidence contained in the record submitted by the Government. 21 CFR 1301.43(d) & (e). I make the following findings. Findings Registrant is a physician who is currently registered with DEA as a practitioner in schedules II–V at the registered address of 16244 South PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 Military Trail, Suite 490, Delray Beach, Florida 33484. GX 8. Registrant’s registration expires by its terms on February 28, 2015. Id. In July of 2010, Registrant was working as a physician at Pompano Beach Medical, located at 553 E. Sample Road, Pompano Beach, Florida 33064. GX 7. According to the affidavit of a DEA Diversion Investigator, on July 15, 2010, two DEA Task Force Officers (hereinafter, TFO One and TFO Two) conducted undercover visits to this medical facility and were seen by the Registrant. Id. at 2. TFO One’s Visit On July 15, 2010, TFO One conducted an undercover visit at Pompano Beach Medical under the name of Larry Olsen. Id. During this visit, TFO One filled out a follow-up medical form,1 and paid $200 in cash. Id. On this form, TFO One indicated that without medication, his pain level was between zero and two. GX 4, at 3. Before being seen by Registrant, TFO One was seen by Leah Gustavson, a medical assistant. Id. at 1–2; GX 7, at 2. When questioned by Gustavson about his pain level being between zero and two, TFO One stated that ‘‘the pain hasn’t been near as bad as it . . . as it . . . uh . . . You know. It has been good.’’ GX 4, at 3. TFO One informed Gustavson that his pain was good even without medication, as long as he ‘‘watch[ed] what [he is] doing.’’ Id. He also indicated that his pain level had decreased even without the medication, leading Gustavson to indicate that the doctor would probably decrease his dosage. Id. at 4–5. TFO One then informed Gustavson that he ‘‘may miss [his] next visit because [he would be] visiting the Baltimore area,’’ and was concerned about having enough medication to last him through the visit. Id. at 5. Gustavson informed TFO One that ‘‘[w]e’re not allowed to give you extra.’’ Id. Gustavson then asked if TFO One was experiencing any side effects from his medication. Id. at 5–6. TFO One stated that he did not have any side effects, and noted that he does not ‘‘really get sick of medication . . . to be honest with you.’’ Id. at 6. However, TFO One indicated that he was 1 TFO One had visited the clinic twice before this visit, once in May, and once in June; at these visits, he was seen by another doctor. GX 7, at 2; GX 3, at 21–22. During the May visit, TFO One received prescriptions for 150 dosage units of oxycodone 30 mg, sixty dosage units of oxycodone 15 mg, and sixty dosage units of carisoprodol. GX 3, at 22. During the June visit, TFO One received prescriptions for 160 dosage units of oxycodone 30 mg, ninety dosage units of oxycodone 15 mg, and sixty dosage units of carisoprodol. Id. at 21. E:\FR\FM\25SEN1.SGM 25SEN1

Agencies

[Federal Register Volume 78, Number 186 (Wednesday, September 25, 2013)]
[Notices]
[Pages 59059-59060]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-23277]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-505 and 731-TA-1231-1237 (Preliminary)]


Grain-Oriented Electrical Steel From China, Czech Republic, 
Germany, Japan, Korea, Poland, and Russia; Institution of Antidumping 
and Countervailing Duty Investigations and Scheduling of Preliminary 
Phase Investigations

AGENCY: United States International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Commission hereby gives notice of the institution of 
investigations and commencement of preliminary phase antidumping and 
countervailing duty investigations Nos. 701-TA-505 and 731-TA-1231-1237 
(Preliminary) under sections 703(a) and 733(a) of the Tariff Act of 
1930 (19 U.S.C. 1671b(a) and 1673b(a)) (the Act) to determine whether 
there is a reasonable indication that an industry in the United States 
is materially injured or threatened with material injury, or the 
establishment of an industry in the United States is materially 
retarded, by reason of imports from China of grain-oriented electrical 
steel (``GOES''), provided for in subheadings 7225.11.00, 7226.11.10, 
and 7226.11.90 of the Harmonized Tariff Schedule of the United States, 
that are alleged to be subsidized by the Government of China and 
imports from China, Czech Republic, Germany, Japan, Korea, Poland, and 
Russia that are alleged to be sold in the United States at less than 
fair value. Unless the Department of Commerce extends the time for 
initiation pursuant to sections 702(c)(1)(B) or 732(c)(1)(B) of the Act 
(19 U.S.C. 1671a(c)(1)(B) or 1673a(c)(1)(B)), the Commission must reach 
a preliminary determination in antidumping and countervailing duty 
investigations in 45 days, or in this case by November 4, 2013. The 
Commission's views are to be issued within five business days 
thereafter, or by November 12, 2013.
    For further information concerning the conduct of these 
investigations and rules of general application, consult the 
Commission's Rules of Practice and Procedure, part 201, subparts A 
through E (19 CFR part 201), and part 207, subparts A and B (19 CFR 
part 207).

DATES:  Effective September 18, 2013.

FOR FURTHER INFORMATION CONTACT:  Mary Messer (202-205-3193), Office of 
Investigations, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436. Hearing-impaired persons can obtain information 
on this matter by contacting the Commission's TDD terminal on 202-205-
1810. Persons with mobility impairments who will need special 
assistance in gaining access to the Commission should contact the 
Office of the Secretary at 202-205-2000. General information concerning 
the Commission may also be obtained by accessing its internet server 
(http://www.usitc.gov). The public record for these investigations may 
be viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov.

SUPPLEMENTARY INFORMATION:
    Background.--These investigations are being instituted in response 
to a petition filed on September 18, 2013, by AK Steel Corporation, 
West Chester, Ohio; Allegheny Ludlum, LLC, Pittsburgh, Pennsylvania; 
and the United Steelworkers, Pittsburgh, Pennsylvania.
    Participation in the investigations and public service list.--
Persons (other than petitioners) wishing to participate in the 
investigations as parties must file an entry of appearance with the 
Secretary to the Commission, as provided in sections 201.11 and 207.10 
of the Commission's rules, not later than seven days after publication 
of this notice in the Federal Register. Industrial users and (if the 
merchandise under investigation is sold at the retail level) 
representative consumer organizations have the right to appear as 
parties in Commission antidumping and countervailing duty 
investigations. The Secretary will prepare a public service list 
containing the names and addresses of all persons, or their 
representatives, who are parties to these investigations upon the 
expiration of the period for filing entries of appearance.
    Limited disclosure of business proprietary information (BPI) under 
an administrative protective order (APO) and BPI service list.--
Pursuant to section 207.7(a) of the Commission's rules, the Secretary 
will make BPI gathered in these investigations available to authorized 
applicants representing interested parties (as defined in 19 U.S.C. 
1677(9)) who are parties to the investigations under the APO issued in 
the investigations, provided that the application is made not later 
than seven days after the publication of this notice in the Federal 
Register. A separate service list will be maintained by the Secretary 
for those parties authorized to receive BPI under the APO.
    Conference.--The Commission's Director of Investigations has 
scheduled a conference in connection with these investigations for 9:30 
a.m. on October 9, 2013, at the U.S. International Trade Commission 
Building, 500 E Street SW., Washington, DC. Requests to appear at the 
conference should be filed with William.Bishop@usitc.gov and 
Sharon.Bellamy@usitc.gov (DO NOT FILE ON EDIS) on or before October 7, 
2013. Parties in support of the imposition of countervailing and 
antidumping duties in these investigations and parties in opposition to 
the imposition of such duties will each be collectively allocated one 
hour within which to make an oral presentation at the conference. A 
nonparty who has testimony that may aid the Commission's deliberations 
may request permission to present a short statement at the conference.
    Written submissions.--As provided in sections 201.8 and 207.15 of 
the Commission's rules, any person may submit to the Commission on or 
before October 15, 2013, a written brief containing information and 
arguments pertinent to the subject matter of the investigations. 
Parties may file written testimony in connection with their 
presentation at the conference no later than three days before the 
conference. If briefs or written testimony contain BPI, they must 
conform with the

[[Page 59060]]

requirements of sections 201.6, 207.3, and 207.7 of the Commission's 
rules. The Commission's Handbook on E-Filing, available on the 
Commission's Web site at http://edis.usitc.gov, elaborates upon the 
Commission's rules with respect to electronic filing.
    In accordance with sections 201.16(c) and 207.3 of the rules, each 
document filed by a party to the investigations must be served on all 
other parties to the investigations (as identified by either the public 
or BPI service list), and a certificate of service must be timely 
filed. The Secretary will not accept a document for filing without a 
certificate of service.

    Authority: These investigations are being conducted under 
authority of title VII of the Tariff Act of 1930; this notice is 
published pursuant to section 207.12 of the Commission's rules.

    Issued: September 19, 2013.

    By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2013-23277 Filed 9-24-13; 8:45 am]
BILLING CODE 7020-02-P